GLP-1 with Hydreight: Semaglutide, Tirzepatide, Sermorelin
We invited the founder of Healthcare Prosoft PCs, Dr. Palumbo, and Pharmacist Lindsey Urbatchka for an exclusive webinar to provide valuable insights into the medical model, structure, and the benefits of compliance in the ever-changing healthcare industry, with a special focus on GLP1-Services, IV Therapies, and NAD+.
Watch Replay
Semaglutide's Rise to Stardom:
- Popularity and Demand: Semaglutide is currently one of the most sought-after medical services in the United States. Its effectiveness in managing diabetes and obesity has garnered widespread attention among healthcare professionals and patients alike. The demand for Semaglutide services has never been higher, with millions of Americans looking for ways to improve their health and quality of life.
- Fueled by Celebrity Endorsements: Semaglutide's ascent to fame has been further propelled by celebrity endorsements, underlining its position as the ultimate solution for weight loss. The power of influential figures has amplified its reach and appeal, making it a household name.
- FDA's Shortage List: Last year, Semaglutide injection earned its place on the FDA's shortage list, a testament to its soaring demand. Even today, it remains in high demand, indicating the urgency for innovative and accessible solutions.
Semaglutide Market Insights:
- Valuation: In 2021, the Semaglutide market was valued at an impressive USD $2.17 Billion and $6 Billion in 2023. This is just the beginning of its remarkable journey. Market experts predict its value to skyrocket, reaching a staggering USD $100 Billion per year by 2030.
- Future Growth: The future of the Semaglutide market holds tremendous potential. As the need for effective weight management solutions continues to surge, Semaglutide stands at the forefront, ready to meet this demand head-on. By joining the Hydreight platform, you are positioning yourself at the epicenter of an industry set to redefine healthcare.
Now, here's where Hydreight comes in and sets itself apart from the competition. Hydreight is proud to be the industry leader, offering a groundbreaking service that sets us apart from the competition. Through our revolutionary software platform, licensed healthcare providers like you are able to conduct mobile lab services (a requirement for Semaglutide) and pharmacies are able to arrange for medication deliveries right to your clients’ homes.
The Hydreight platform allows you to visit your clients in the comfort of their homes to conduct the blood draws, check their BMI and educate the client on Semaglutide and how to self administer the product. After the home visit, the Semaglutide will then be shipped directly to the client, who will self-administer it. After that, you will only be required to provide monthly check-ins to ensure your clients are healthy and happy.
What makes this opportunity even more enticing is that you will not be burdened with the upfront costs of the Semaglutide product or be liable for its administration. Your sole focus will be on providing vital measurements and guidance to clients, ensuring their journey to better health is seamless and hassle-free. This means that you can focus on providing the essential measurements and guidance to clients, without the financial burden typically associated with the provision of medical services.
The Healthcare Concierge Program. This extraordinary opportunity is exclusive to Hydreight subscribers.
- This program allows you to offer Semaglutide and Tirzepatide in the GLP1 space. As well as Sermorelin in the peptide space.
- Your subscription will start with the compounded Vial (which is what is widely offered now) and soon you will have the opportunity to offer the compounded pen version (no competitor is offering this), and the actual branded pen versions.
This is the most sought after medical service in the history of the country
- Hydreight is the only company that offers patients various options and price points due Hydreight's Pharmaceutical network.
- No other company is doing a lab test, nor has a medical professional who visits them. We are the ONLY company approaching this from a healthcare perspective vs a profit perspective.
- There is no entry point for healthcare professionals with this service. Hydreight is the only company to provide this level of healthcare.
- This truly patient specific
- Any establishment that administers this medication is operating illegally.
- This is a patient specific medication, so it must be sent directly to the patient and the patient is the only person who is allowed to inject it.
- We have a 100+ Dr. network available to help you, which makes us even more unique in the market.
Patients & healthcare professionals want this level of healthcare, it just hasn't been available - until now.
- You can be the first one who provides it in your town and collect all of the benefits.
Potential GLP-1 Revenue Example: For reference, most companies are charging between $399-$599/mth. We will use this for our example but I will show you the profit, since the client covers the cost of the medication.
- 1 client x $200/mth = $200/mth or $2,400/year
- 10 clients x $200/mth = $2,000/mth profit or $24,000/year
- 100 clients x $200/mth = $20,000/mth or $240,000/year
So, what's required to achieve these financial milestones?
It's simpler than you might think. You'll visit your clients once a month for just 15 minutes.
- During the first visit, you'll measure BMI, take a blood sample, and send it to Hydreight.
- Hydreight will formulate the injection based on the blood sample and BMI, then send it directly to the client.
- The client will administer weekly injections.
- Subsequent visits will primarily involve quick 10 minute check-ins at the end of each month, with occasional measurements or blood draws.
Importantly, you won't be responsible for ordering products, transporting them, or maintaining inventory. This program empowers you to focus on what you do best – providing exceptional care. Everything else is 100% seamless and handled by the Hydreight team. So there is no risk!
